Are pyridazines privileged structures?
Tóm tắt
Compared to carbocyclic drug molecules, pyridazine-containing drugs present additional interaction possibilities, as illustrated here for the antirhinoviral agent R 61837.
Từ khóa
Tài liệu tham khảo
Wermuth, 1965, Bull. Soc. Chim. Fr., 2242
Wermuth, 1966, Bull. Soc. Chim. Fr., 1435
Laborit, 1965, Agressologie, 6, 401
G. Heinisch and H.Frank , Pharmacologically Active Pyridazines. Part 1 , in Progress in Medicinal Chemistry , ed. G. P. Ellis and G. B. West , Elsevier , Amsterdam , 1990 , vol. 27 , pp. 1–49
G. Heinisch and H.Kopelenk-Frank , Pharmacologically Active Pyridazines. Part 2 , in Progress in Medicinal Chemistry , ed. G. P. Ellis and D. K. Luscombe , Elsevier , Amsterdam , 1992 , vol. 29 , pp. 141–183
B. E. Evans , K. E.Rittle , M. G.Bock , R. M.DiPardo , R. M.Freidinger , W. L.Whitter , G. F.Lundell , D. F.Veber , P. S.Anderson , R. S. L.Chang , V. J.Lotti , D. J.Cerino , T. B. P. J. K.Chen , K. A.Kunkel , J. P.Springer and J.Hirshfield , Methods for Drug Discovery: Development of Potent, Selective, Orally Effective Cholecystokinin Antagonists , J. Med. Chem. , 1988 , 31 , 22352246
K. Russell and W. F.Michne , The Value of Chemical Genetics in Drug Discovery , in Chemogenomics in Drug Discovery , ed. H. Kubinyi and G. Müller , VCH , 2004 , pp. 69–96
A. Kolinsky , Lead-Likeness and Drug-Likeness , in The Practice of Medicinal Chemistry , ed. C. G. Wermuth , Elsevier , San Diego , 2008 , pp. 244–254